COVID-19 (coronavirus) planning for people with diabetes 11 March 2020 The COVID-19 (coronavirus) pandemic threat is being addressed by all Australian Governments and health services. People with diabetes may be concerned about their risk, and also the availability of insulin and other essential medicines and their National Diabetes Services Scheme (NDSS) products and supplies. The Department of Health has advised Diabetes Australia that there are no current shortages or supply issues with insulin, diabetes medicines or NDSS products. People with diabetes are advised to order and obtain your diabetes medicines and supplies as usual. There is no need to stockpile. The Australian Government plan to fight the COVID-19 threat includes provision of bulk-billed telehealth medical services, home medicine deliveries, support for additional aged care staff and increased service capacity for First Nations People in remote locations. Pharmacies with e-prescribing will be eligible to participate in the home medicines services. New Medicare telehealth services will commence from Friday 13 March. Telehealth consultations will be provided by GPs and specialists, nurses and mental health allied health workers. They will be available under Medicare for people aged over 70, those with chronic conditions (including diabetes), First Nations People aged over 50, people who are immunocompromised, pregnant women and parents with new babies. Diabetes Australia will continue to consult with the Australian Government and the Department of Health to ensure people with diabetes can access the latest information to help them stay safe and healthy during this time. For more information visit the Australian Government’s Coronavirus Information Page. This page is updated regularly. If you have questions about COVID-19 please call the Australian Government’s Coronavirus Health Information Line on 1800 020 080. The helpline operates 24 hours a day, seven days a week. 11 March 2019
Partners 28 November 2023 Dexcom G6 Continuous Glucose Monitoring (CGM) – For people living with Type 1, Type 2 and Gestational Diabetes*Trial now for only $32.10!† Advertisement ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on dexcom.com/downloadsandguides before purchasing. Consult... Continue Reading
Partners 28 November 2023 Glucose readings every minute for you† and your loved ones* Advertisement The latest version of the FreeStyle LibreLink app† now allows you to receive continuous glucose readings on your phone,... Continue Reading
Media releases 24 November 2023 New vitamin C diabetes research announced Deakin University’s Professor Glenn Wadley is a recipient of one of this year’s Diabetes Australia Research Program (DARP) grants to study the efficacy of vitamin C in the treatment of foot ulcers in people living with diabetes, which can lead to amputations. Continue Reading